Analyst Ratings for Monsanto (MON) [Buys]
MON Rating Summary
MON Price Target Summary
- Highest: $120.00 (Credit Suisse)
- Lowest: $73.00 (JPMorgan)
- Average: $96.93
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$96.93 (-10.6%)
Avg. $ Target:
$96.93 (-10.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/17/2013 | Credit Suisse | New Coverage | Outperform (N/A) |
120.00 (N/A) |
101.90 | 108.38 | 6.36% | Details |
| 11/20/2012 | Topeka Capital | Upgrade | Buy (Hold) |
107.00 (N/A) |
88.33 | 108.38 | 22.7% | Details |
| 11/5/2012 | Monness, Crespi, Hardt | Upgrade | Buy (Neutral) |
100.00 (N/A) |
85.87 | 108.38 | 26.21% | Details |
| 9/27/2012 | Wells Fargo | Upgrade | Outperform (Market Perform) |
105.00 (83.00) |
89.49 | 108.38 | 21.11% | Details |
| 9/19/2012 | Goldman Sachs » Updated 3/26/2013 |
Upgrade | Conviction Buy (Buy) |
116.00 (N/A) |
89.06 | 108.38 | 21.69% | Details |
| 5/30/2012 | Canaccord Genuity | Upgrade | Buy (N/A) |
89.00 (N/A) |
76.74 | 108.38 | 41.23% | Details |
| 10/6/2011 | JPMorgan | Upgrade | Overweight (N/A) |
73.00 (N/A) |
66.25 | 108.38 | 63.59% | Details |
| 9/13/2011 | Chardan Capital | Upgrade | Buy (N/A) |
85.00 (N/A) |
65.87 | 108.38 | 64.54% | Details |
| 8/10/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
67.29 | 108.38 | 61.06% | Details |
| 8/2/2011 | Credit Agricole | Upgrade | Buy (N/A) |
100.00 (N/A) |
72.35 | 108.38 | 49.8% | Details |
| 4/11/2011 | Deutsche Bank » Updated 8/16/2012 |
Upgrade | Buy (N/A) |
100.00 (92.00) |
66.22 | 108.38 | 63.67% | Details |
| 1/11/2011 | Argus | Upgrade | Buy (N/A) |
N/A (N/A) |
71.37 | 108.38 | 51.86% | Details |
| 1/4/2011 | Soleil Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
68.86 | 108.38 | 57.39% | Details |
| 12/6/2010 | Gabelli | New Coverage | Buy (N/A) |
N/A (N/A) |
62.82 | 108.38 | 72.52% | Details |
| 11/5/2010 | Piper Jaffray | New Coverage | Overweight (N/A) |
N/A (N/A) |
62.82 | 108.38 | 72.52% | Details |
